Revealing the nature of cardiovascular disease using DERGA, a novel data ensemble refinement greedy algorithm

Panagiotis G Asteris1, Eleni Gavriilaki2, Polydoros N Kampaktsis3

  • 1Computational Mechanics Laboratory, School of Pedagogical and Technological Education, Athens, Greece.

Insights

This study identifies key cardiovascular disease (CVD) predictors using an AI algorithm. Platelet-derived Microvesicles (PMV), hypertension, and BMI are crucial for accurate CVD risk prediction.

Area of Science:

  • Cardiology
  • Artificial Intelligence
  • Biomedical Data Science

Background:

  • Cardiovascular disease (CVD) poses a significant global health challenge.
  • Accurate prediction of CVD risk is essential for early intervention and management.
  • Identifying key predictive parameters is crucial for developing effective diagnostic tools.

Purpose of the Study:

  • To determine the most crucial parameters associated with cardiovascular disease (CVD).
  • To employ a novel data ensemble refinement procedure to uncover the optimal pattern of these parameters for high prediction accuracy.
  • To enhance early diagnosis and optimize resource utilization in CVD risk assessment.

Main Methods:

  • Analysis of data from 369 patients (281 with CVD or at risk, 88 healthy).
  • Utilized an artificial intelligence-based algorithm, including DERGA and Extra Trees, for pattern identification.
  • Evaluated the predictive power of various parameters, including Platelet-derived Microvesicles (PMV), hypertension, age, smoking, dyslipidemia, and Body Mass Index (BMI).

Main Results:

  • A six-parameter combination, including PMV, hypertension, age, smoking, dyslipidemia, and BMI, effectively discerns CVD likelihood.
  • The highest prediction accuracy achieved was 98.64%.
  • Platelet-derived Microvesicles (PMV) alone yielded 91.32% accuracy, while a ten-parameter model achieved 97.83% accuracy.

Conclusions:

  • The DERGA algorithm effectively identifies critical parameters for CVD risk assessment.
  • This approach accelerates CVD risk assessment, enabling earlier diagnosis and reducing the need for extensive lab tests.
  • The findings enhance understanding of CVD susceptibility and optimize resource allocation in healthcare.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
134
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
347
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.2K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
532
Cardiac Output and Stroke Volume01:11

Cardiac Output and Stroke Volume

Cardiac output (CO) is an integral aspect of human physiology, reflecting the heart's efficiency and responsiveness to the body's needs. It represents the volume of blood that the left or right ventricle ejects into the aorta or pulmonary trunk each minute. The CO is calculated by multiplying the heart rate (HR)—the number of heartbeats per minute—by the stroke volume (SV)—the amount of blood pumped out with each heartbeat.
In an average resting adult male, the typical cardiac...
2.9K